Ecstasy pills tested as breakthrough treatment for untreatable pain

NCT ID NCT07301632

Summary

This small pilot study is testing whether MDMA (commonly known as ecstasy), combined with psychotherapy, can help people with severe, treatment-resistant nerve pain. Forty adults with long-term, debilitating pain will receive either MDMA or an active placebo during a guided therapy session, followed by several weeks of integration therapy. The main goal is to see if this approach is safe and feasible to study in a larger trial, while also checking if it meaningfully reduces pain and improves daily life after 16 weeks.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC NEUROPATHIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • St. Michael's Hospital

    RECRUITING

    Toronto, Ontario, M5B 1W8, Canada

    Contact

Conditions

Explore the condition pages connected to this study.